UA36974A - METHOD OF TREATMENT OF CONGENITAL AND ACQUIRED TOXOPLASMOSIS IN CHILDREN - Google Patents

METHOD OF TREATMENT OF CONGENITAL AND ACQUIRED TOXOPLASMOSIS IN CHILDREN

Info

Publication number
UA36974A
UA36974A UA2000031262A UA200031262A UA36974A UA 36974 A UA36974 A UA 36974A UA 2000031262 A UA2000031262 A UA 2000031262A UA 200031262 A UA200031262 A UA 200031262A UA 36974 A UA36974 A UA 36974A
Authority
UA
Ukraine
Prior art keywords
treatment
children
congenital
toxoplasmosis
acquired
Prior art date
Application number
UA2000031262A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Лариса Володимирівна Пипа
Лариса Владимировна Пипа
Original Assignee
Вінницький Державний Медичний Університет Ім. М.І. Пирогова
Винницький Государственный Медицинский Университет Им. М.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вінницький Державний Медичний Університет Ім. М.І. Пирогова, Винницький Государственный Медицинский Университет Им. М.И. Пирогова filed Critical Вінницький Державний Медичний Університет Ім. М.І. Пирогова
Priority to UA2000031262A priority Critical patent/UA36974A/en
Publication of UA36974A publication Critical patent/UA36974A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, in particular to the paediatrics, and it may be used for treatment of toxoplasmosis. A method for treatment of congenital and acquired toxoplasmosis in children includes the administration of fansidar at a dose of 1-15 mg/kg of body mass 1 time per a week during 6-8 weeks. Fansidar is prescribed to the children of different age groups, since the period of new-bornness as monotherapy and only at the presence of neurological symptomatology it is combined with spiramycin (a macrolide antibiotic).
UA2000031262A 2000-03-03 2000-03-03 METHOD OF TREATMENT OF CONGENITAL AND ACQUIRED TOXOPLASMOSIS IN CHILDREN UA36974A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2000031262A UA36974A (en) 2000-03-03 2000-03-03 METHOD OF TREATMENT OF CONGENITAL AND ACQUIRED TOXOPLASMOSIS IN CHILDREN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2000031262A UA36974A (en) 2000-03-03 2000-03-03 METHOD OF TREATMENT OF CONGENITAL AND ACQUIRED TOXOPLASMOSIS IN CHILDREN

Publications (1)

Publication Number Publication Date
UA36974A true UA36974A (en) 2001-04-16

Family

ID=74182011

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2000031262A UA36974A (en) 2000-03-03 2000-03-03 METHOD OF TREATMENT OF CONGENITAL AND ACQUIRED TOXOPLASMOSIS IN CHILDREN

Country Status (1)

Country Link
UA (1) UA36974A (en)

Similar Documents

Publication Publication Date Title
EP1708685A4 (en) Effervescent oral opiate dosage forms and methods of administering opiates
TW200518784A (en) Azithromycin dosage forms with reduced side effects
AP9801420A0 (en) Novel macrolides.
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
MY128362A (en) Spontaneously dispersible n-benzoyl staurosporine compositions
IS6558A (en) Mixed disease treatment with vasoconstrictor
SE0001518L (en) Pharmaceutical composition
HUP0105481A2 (en) Pharmaceutical compositions containing clarithromycin and process for their preparation and their use
UA36974A (en) METHOD OF TREATMENT OF CONGENITAL AND ACQUIRED TOXOPLASMOSIS IN CHILDREN
AP2218A (en) Azithromycin dosage forms with reduced side effects
GEP20094596B (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction
UA36093A (en) Method for treating chronic bronchitis